CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +94,285 | 94,285 | ||
| 2024-02-12 | Parlavecchio Caryn CHRO | Grant or award | +47,145 | 161,495 | ||
| 2024-02-12 | Parlavecchio Caryn CHRO | Grant or award · Stock Option (Right to Buy) | +62,855 | 62,855 | ||
| 2024-02-12 | Myles Edward H COO & CFO | Grant or award | +53,570 | 215,720 | ||
| 2024-02-12 | Myles Edward H COO & CFO | Grant or award · Stock Option (Right to Buy) | +71,430 | 71,430 | ||
| 2024-02-12 | Ho Junlin GENERAL COUNSEL | Grant or award | +57,855 | 212,260 | ||
| 2024-02-12 | Ho Junlin GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +77,145 | 77,145 | ||
| 2024-01-16 | Qatanani Mo SVP AND HEAD OF RESEARCH | Sale | −2,002 | $15.93 | $32K | 78,816 |
| 2024-01-16 | Parlavecchio Caryn CHRO | Sale | −2,849 | $15.93 | $45K | 114,350 |
| 2024-01-16 | Myles Edward H COO & CFO | Sale | −6,634 | $15.93 | $106K | 162,150 |
| 2024-01-16 | Ho Junlin GENERAL COUNSEL | Sale | −4,186 | $15.93 | $67K | 154,405 |
| 2023-12-29 | Myles Edward H COO & CFO | Exercise or conversion 10b5-1 | +12,459 | $4.86 | $61K | 181,243 |
| 2023-12-29 | Myles Edward H COO & CFO | Sale 10b5-1 | −12,159 | $18.82 | $229K | 169,084 |
| 2023-12-29 | Myles Edward H COO & CFO | Sale 10b5-1 | −300 | $19.51 | $6K | 168,784 |
| 2023-12-29 | Myles Edward H COO & CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −24,914 | 49,836 | ||
| 2023-12-27 | Nashat Amir Director | Gift | −21,333 | 25,506 | ||
| 2023-12-21 | Burow Kristina Director | Other disposition | −291,906 | 2,345,711 | ||
| 2023-12-21 | Burow Kristina Director | Other acquisition | +5,339 | 5,339 | ||
| 2023-12-14 | Qatanani Mo SVP AND HEAD OF RESEARCH | Exercise or conversion | +8,437 | $10.00 | $84K | 105,480 |
| 2023-12-14 | Qatanani Mo SVP AND HEAD OF RESEARCH | Sale | −24,662 | $18.18 | $448K | 80,818 |
Page 17 of 22 · 422 trades